Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice.

× No keyword cloud information.

2 in total

1. Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity--I. Disease modifying action on adjuvant arthritis of the rat.

Authors: R R Bartlett; R Schleyerbach
Journal: Int J Immunopharmacol Date: 1985

2. Immunopharmacological profile of HWA 486, a novel isoxazol derivative--II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A.

Authors: R R Bartlett
Journal: Int J Immunopharmacol Date: 1986

2 in total

7 in total

Review 1. Ten years research on inflammation revisited.

Authors: K Brune
Journal: Agents Actions Date: 1989-01

Review 2. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.

Authors: R R Bartlett; M Dimitrijevic; T Mattar; T Zielinski; T Germann; E Rüde; G H Thoenes; C C Küchle; H U Schorlemmer; E Bremer
Journal: Agents Actions Date: 1991-01

Review 3. Effects of leflunomide on immune responses and models of inflammation.

Authors: R R Bartlett; H Anagnostopulos; T Zielinski; T Mattar; R Schleyerbach
Journal: Springer Semin Immunopathol Date: 1993

Review 4. Leflunomide: mode of action in the treatment of rheumatoid arthritis.

Authors: F C Breedveld; J M Dayer
Journal: Ann Rheum Dis Date: 2000-11 Impact factor: 19.103

5. Effects of leflunomide on glomerulonephritis induced by antibasement membrane antibody in rats.

Authors: T Ogawa; M Inazu; K Gotoh; S Hayashi
Journal: Agents Actions Date: 1990-11

6. Effects of leflunomide on inflamation and fibrosis in bleomycine induced pulmonary fibrosis in wistar albino rats.

Authors: Servet Kayhan; Aygul Guzel; Latif Duran; Serife Tutuncu; Ahmet Guzel; Mithat Gunaydın; Osman Salis; Ali Okuyucu; Mustafa Yasin Selcuk
Journal: J Thorac Dis Date: 2013-10 Impact factor: 2.895

7. 4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr mice.

Authors: Onkar P Kulkarni; Sufyan G Sayyed; Claudia Kantner; Mi Ryu; Max Schnurr; Miklós Sárdy; Johann Leban; Ruediger Jankowsky; Aldo Ammendola; Robert Doblhofer; Hans-Joachim Anders
Journal: Am J Pathol Date: 2010-04-22 Impact factor: 4.307

7 in total